Target intelligence / Profile preview

DNABII family protein (DNABII)

Target
DNABII
Molecular classification
DNA-binding protein, Nucleoid-associated protein, Transcription factor
01

Overview

DNABII family proteins, primarily consisting of Integration Host Factor (IHF) and Histone-like protein (HU), are highly conserved bacterial nucleoid-associated proteins that serve as essential structural components of the extracellular DNA (eDNA) matrix in biofilms (Goodman et al., 2011). These proteins bind to and stabilize the junctions of bent or crossed DNA strands, acting as the physical "linchpins" that maintain the integrity of the biofilm's protective scaffold (Novotny et al., 2013). In the context of human disease, biofilms significantly enhance bacterial resistance to antibiotics and shield pathogens from the host immune system, leading to chronic infections such as those seen in cystic fibrosis, chronic otitis media, and non-healing wounds (Estelles et al., 2016). Therapeutic strategies targeting DNABII proteins utilize monoclonal antibodies, such as TRL1070, to sequester these proteins from the eDNA matrix. This action causes the rapid physical collapse of the biofilm structure, dispersing the bacteria into a planktonic state where they are highly vulnerable to conventional antibiotics and immune-mediated clearance (Trellis Bioscience, 2024). This approach represents a novel "anti-virulence" strategy that does not directly kill bacteria but instead removes their primary defense mechanism.

Other names
Integration host factorIHFHistone-like proteinHUNucleoid-associated proteinNAPDNA-binding protein from irradiated cells II
02

Mechanism of action

Antibody-mediated sequestration of DNABII proteins from the extracellular DNA matrix, resulting in the loss of biofilm structural integrity and increased bacterial susceptibility to antibiotics and immune clearance (Estelles et al., 2016).

03

Biological functions

DNA bendingBiofilm structural maintenanceDNA packagingTranscription regulationSite-specific recombination
04

Disease associations

Bacterial infectionCystic fibrosisOtitis mediaChronic wound infectionUrinary tract infectionPeriodontitis
05

Safety considerations

Potential for off-target effects on the host's commensal microbiomeImmunogenicity of therapeutic monoclonal antibodiesRisk of systemic inflammatory response during rapid biofilm dissolution
06

Interacting drugs

TRL1070
07

Biomarkers

Biofilm-associated extracellular DNA (eDNA) levelsBacterial load in clinical samples

Beyond the preview

Go deeper on DNABII family protein (DNABII).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on DNABII family protein (DNABII).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call